by Madhusmita Rout, Christopher E. Aston, Ravindranath Duggirala, Harald H.
Goring, Oliver Fiehn, Dharambir K. Sanghera Background Genetic mechanisms that predispose people to type 2 diabetes (T2D) and cardiovascular disease (CVD) remain poorly understood, partly because of a lack of sufficient data on non-European ethnic groups.
Extending these evaluations to diverse cohorts is essential for gaining insights into the molecular pathways involved in disease development among human populations. In this study, we aimed to evaluate the genetic connection between the human lipidome and cardiometabolic disorders.
We conducted a metabolite genome-wide association study (mGWAS) in a Punjabi population from India, along with multi-layer replication studies using the UK Biobank and other independent European and non-European cohorts. Methods and findings We performed mGWAS using 516 lipid metabolites in 3,000 Punjabi Sikh individuals, and validation was performed in 1.13M Europeans and 15K individuals from Asian Indian ancestry using independent cohorts of the UK Biobank, GeneRISK, DIAMANT, PROMIS, and other studies.
We identified 609 SNP-metabolite associations representing 236 SNP-metabolite pairs that attained genome-wide significance ( p −8 ).
PLOS Medicine published a clinical update in Research Highlights on 23 Apr 2026.
The item focuses on Identification of lipid quantitative trait loci linked with cardiometabolic disease in Asian Indians and Europeans: A genome-wide association study and mendelian randomization.
Review the original article for the full source wording and details.